Skip to main content

Table 1 HPLC / MS parameters for marker substrate and marker metabolite separation and detection

From: Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities

CYP

Iso-enzyme

Marker substrate

Marker metabolite

Gradient/isocratic

Injection

volume

[μl]

Flow

rate

[ml/min]

Column

temp.

[°C]

Stop

time

[min]

Detection

2A6

coumarin

umbelliferone

0–6 min linear

10

0.4

30

8

Transition (m/z) 163.0 > 107.0

2B6

S-mephenytoin

nirvanol

0–4 min linear

10

0.4

30

6

Transition (m/z) 205.0 > 134.0

2C8

paclitaxel

6α-hydroxypaclitaxel

0–6 min linear

10

0.4

30

7.5

Transition (m/z) 870.2 > 524.9

2C9

diclofenac

4′-hydroxydiclofenac

0–6 min linear

10

0.4

30

7

SIR (m/z) 265.9 / 249.9

2C19

S-mephenytoin

4′-hydroxymephenytoin

0–6 min linear

10

0.4

30

6

Transition (m/z) 235.0 > 150.2

2D6

bufuralol

hydroxybufuralol

0–6 min linear

10

0.4

30

8

MRM (m/z) 278.2 > 186.1

2E1

chlorzoxazone

6-hydroxychlorzoxazone

Isocratic

20

0.5

30

8

Absorption at 298 nm

3A4

testosterone

6β-hydroxytestosterone

0–6 min linear

10

0.4

30

7.5

Transition (m/z) 305.0 > 287.0

  1. m/z mass-to-charge ratio, SIR selected ion recording, MRM multiple reaction monitoring